FACTORS DETERMINING BONE MINERAL DENSITY LOSS IN CHRONIC HEPATITIS B PATIENTS: IS TENOFOVIR DISOPROXIL FUMARATE THE MAIN CULPRIT?

被引：3
|
作者：
Gill, U. S. [1 ]
Al-Shamma, S. [1 ]
Burke, K. [1 ]
Ross, V. [1 ]
Kooner, P. [1 ]
Marley, R. [1 ]
Foster, G. R. [1 ]
Kennedy, P. T. F. [1 ]
机构：
[1] Barts & London Queen Marys Sch Med & Dent, London, England
来源：
JOURNAL OF HEPATOLOGY | 2011年 / 54卷
关键词：
D O I：
10.1016/S0168-8278(11)60715-0
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
713
引用
收藏
页码：S286 / S286
页数：1
相关论文
共 50 条
  • [21] EFFECTS OF TENOFOVIR ALAFENAMIDE FUMARATE VERSUS TENOFOVIR DISOPROXIL FUMARATE ON SERUM LIPID PROFILES IN PATIENTS WITH CHRONIC HEPATITIS B
    Cao, Fei
    Fan, Tao
    Jiang, Xue
    Wang, Jian
    Xiong, Ye
    Zhang, Shaoqiu
    Zhang, Zhiyi
    Liu, Xingxiang
    Zhu, Chuanwu
    Li, Jie
    Huang, Rui
    Wu, Chao
    HEPATOLOGY, 2024, 80 : S298 - S298
  • [22] Editorial: changes in renal function and bone mineral density after switching from tenofovir disoproxil fumarate to tenofovir alafenamide in chronic hepatitis B patients-author's reply
    Papatheodoridis, George V.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2022, 56 (05) : 918 - 919
  • [23] 96-Week Treatment of Tenofovir Amibufenamide and Tenofovir Disoproxil Fumarate in Chronic Hepatitis B Patients
    Liu, Zhihong
    Jin, Qinglong
    Zhang, Yuexin
    Gong, Guozhong
    Wu, Guicheng
    Yao, Lvfeng
    Wen, Xiaofeng
    Gao, Zhiliang
    Huang, Yan
    Yang, Daokun
    Chen, Enqiang
    Mao, Qing
    Lin, Shide
    Shang, Jia
    Gong, Huanyu
    Zhong, Lihua
    Yin, Huafa
    Wang, Fengmei
    Hu, Peng
    Wu, Qiong
    Pan, Chao
    Jia, Wen
    Li, Chuan
    Sun, Chang'an
    Niu, Junqi
    Hou, Jinlin
    JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY, 2023, 11 (03) : 649 - 660
  • [24] Tenofovir alafenamide and tenofovir disoproxil fumarate reduce incidence of hepatocellular carcinoma in patients with chronic hepatitis B
    Lim, Young-Suk
    Chan, Henry L. Y.
    Ahn, Sang Hoon
    Seto, Wai Kay
    Ning, Qin
    Agarwal, Kosh
    Janssen, Harry L. A.
    Pan, Calvin Q.
    Chuang, Wan Long
    Izumi, Namiki
    Fung, Scott
    Shalimar, Maurizia
    Brunetto, Maurizia
    Hui, Aric Josun
    Chang, Ting-Tsung
    Lim, Seng Gee
    Abramov, Frida
    Flaherty, John F.
    Wang, Hongyuan
    Yee, Leland J.
    Kao, Jia-Horng
    Gane, Edward
    Hou, Jinlin
    Buti, Maria
    JHEP REPORTS, 2023, 5 (10)
  • [25] Combination of Tenofovir Disoproxil Fumarate and Peginterferon α-2a Increases Loss of Hepatitis B Surface Antigen in Patients With Chronic Hepatitis B
    Marcellin, Patrick
    Ahn, Sang Hoon
    Ma, Xiaoli
    Caruntu, Florin A.
    Tak, Won Young
    Elkashab, Magdy
    Chuang, Wan-Long
    Lim, Seng-Gee
    Tabak, Fehmi
    Mehta, Rajiv
    Petersen, Joerg
    Foster, Graham R.
    Lou, Lillian
    Martins, Eduardo B.
    Dinh, Phillip
    Lin, Lanjia
    Corsa, Amoreena
    Charuworn, Prista
    Subramanian, G. Mani
    Reiser, Hans
    Reesink, Hendrick W.
    Fung, Scott
    Strasser, Simone I.
    Huy Trinh
    Buti, Maria
    Gaeta, Giovanni B.
    Hui, Aric J.
    Papatheodoridis, George
    Flisiak, Robert
    Chan, Henry L. Y.
    GASTROENTEROLOGY, 2016, 150 (01) : 134 - +
  • [26] Long-term renal and bone safety of tenofovir disoproxil fumarate in chronic hepatitis B patients with cirrhosis
    Liu, Ken
    Choi, Jonggi
    Le, An
    Wong, Vincent Wai-Sun
    Chan, Stephen L.
    Nguyen, Mindie
    Lim, Young-Suk
    Wong, Grace Lai-Hung
    JOURNAL OF HEPATOLOGY, 2019, 70 (01) : E475 - E476
  • [27] Pharmacotherapy of Chronic Hepatitis B in Adults: Focus on Tenofovir Disoproxil Fumarate
    Jain, Mamta K.
    Zoellner, Cindy L.
    Garg, Kanan
    CLINICAL MEDICINE INSIGHTS-THERAPEUTICS, 2009, 1 : 1291 - 1305
  • [28] Kinetics of hepatitis B surface antigen loss in patients with HBeAg-positive chronic hepatitis B treated with tenofovir disoproxil fumarate
    Marcellin, Patrick
    Buti, Maria
    Krastev, Zahari
    de Man, Robert A.
    Zeuzem, Stefan
    Lou, Lillian
    Gaggar, Anuj
    Flaherty, John F.
    Massetto, Benedetta
    Lin, Lanjia
    Dinh, Phillip
    Subramanian, G. Mani
    McHutchison, John G.
    Flisiak, Robert
    Gurel, Selim
    Dusheiko, Geoffrey M.
    Heathcote, E. Jenny
    JOURNAL OF HEPATOLOGY, 2014, 61 (06) : 1228 - 1237
  • [29] Tenofovir Disoproxil Fumarate versus Adefovir Dipivoxil for Chronic Hepatitis B
    Marcellin, Patrick
    Heathcote, E. Jenny
    Buti, Maria
    Gane, Ed
    de Man, Robert A.
    Krastev, Zahary
    Germanidis, George
    Lee, Sam S.
    Flisiak, Robert
    Kaita, Kelly
    Manns, Michael
    Kotzev, Iskren
    Tchernev, Konstantin
    Buggisch, Peter
    Weilert, Frank
    Kurdas, Oya Ovung
    Shiffman, Mitchell L.
    Trinh, Huy
    Washington, Mary Kay
    Sorbel, Jeff
    Anderson, Jane
    Snow-Lampart, Andrea
    Mondou, Elsa
    Quinn, Joe
    Rousseau, Franck
    NEW ENGLAND JOURNAL OF MEDICINE, 2008, 359 (23): : 2442 - 2455
  • [30] Predictors of HBeAg loss in HBeAg-positive patients with chronic hepatitis B during treatment with tenofovir alafenamide or tenofovir disoproxil fumarate
    Pan, Calvin Q.
    Li, Michael Kin Kong
    Lee, Kwan Sik
    Balabanska, Rozalina I.
    Flaherty, John F.
    Kim, Kyungpil
    Myers, Robert P.
    Subramanian, Mani
    Abdurakhmanov, Djamal
    Ma, Mang M.
    Bae, Ho
    Agarwal, Kosh
    HEPATOLOGY, 2016, 64 : 931A - 931A
12345